Assertio Therapeutics (ASRT) Prices 22.6M Share Registered Direct Offering at $0.62/Sh

Assertio Holdings, Inc. (NASDAQ: ASRT) today announced it has entered into a securities purchase agreement with certain institutional investors to purchase 22,600,000 shares of its common stock at a purchase price of $0.62 per share in a registered direct offering.

Roth Capital Partners acted as the sole placement agent in connection with the offering.

The offering is expected to close on February 9, 2021, subject to customary closing conditions. The gross proceeds to the Company from the registered direct offering are estimated to be approximately $14.0 million before deducting the placement agent’s fees and other estimated offering expenses.

The Company intends to use proceeds from the offering for general corporate purposes, including general working capital.

The securities described above are being offered pursuant to a shelf registration statement on Form S-3 (File No. 333-252368), which was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on February 4, 2021.

You May Also Be Interested In

• Gaxos.ai raises $3.6M through warrant exercise transaction
• Tractor Supply (TSCO) files mixed shelf
• XTEND wins $15M NATO defense contract ahead of NYSE listing